143653-53-6

Abciximab is a glycoprotein IIb/IIIa receptor antagonist and a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery.